This test has the potential ability to detect early cancers and precancerous polyps with greater accuracy." Dr Alexandre Akoulitchev, OBD's Chief Scientific Officer added: "Reliable and non ...

Depending on the type of polyps, they can be benign, be a sign of inflammation, or potentially lead to cancer. Polyps are abnormal tissue growths. Most people with gallbladder polyps do not ...

People with first-degree relatives who were repeatedly diagnosed with colorectal polyps appeared at increased risk for ...

Results of multi-institutional clinical study published in peer reviewed journal ‘Cancers’ confirms efficacy of Oxford BioDynamics’ EpiSwitch® blood-based Colorectal No-Stool Test (NST) Discussions ...

OXFORD, England, February 05, 2025--(BUSINESS WIRE)--Oxford BioDynamics, Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests based on the EpiSwitch® 3D ...

Results of multi-institutional clinical study published in peer reviewed journal 'Cancers' confirms efficacy ofOxford BioDynamics' EpiSwitch blood-based Colorectal No-Stool Test (NST) High ...

The risk for colorectal cancer was associated with the frequency of colorectal polyp diagnoses in relatives in a study based ...

Oxford BioDynamics, Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests based on the EpiSwitch® 3D genomics platform, announces the publication of compelling ...